AParadise III Acquisition Corp.

What the company does

No publishable business summary is available from the effective-prospectus read.

Use of proceeds

The company will place $100,000,000, or $115,000,000 if the underwriters' over-allotment option is exercised in full, into a U.S.-based trust account. Net proceeds not held in the trust account will be used for accounting, due diligence, travel, legal and accounting fees related to regulatory reporting obligations, NYSE and other regulatory fees, and working capital.

Underwriters

Extracted from S-1 0001213900-26-116922, filed Nov 6, 2026 and verified against that filing text.

Key risk factors

• Redemption rights

  “Notwithstanding the foregoing redemption rights, if we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the shares sold in this offering without our prior consent.”

• Founder-share dilution

  “The low price that our initial shareholders (directly or indirectly) paid for the founder shares creates an incentive whereby our officers and directors could potentially make a substantial profit even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders.”

• Conflicts of interest

  “Our initial shareholders, their affiliates, or promoters and members of our management team will directly or indirectly own founder shares, ordinary shares, units or other instruments, such as rights and shares underlying our private placement units, following this offering and, accordingly, may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.”

• Failure to complete a business combination

  “If we are unable to complete our initial business combination within the completion window, or by such earlier liquidation date as our board of directors may approve, the founder shares, the private placement shares and the private placement rights may expire worthless, except to the extent they receive liquidating distributions from assets outside the trust account, which could create an incentive for our sponsor, executive officers and directors to complete a transaction even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders.”